Results 41 to 50 of about 1,483,959 (183)
Identification of JAK2V617F Mutation on Myeloproliferative Disorders in Medan [PDF]
Myeloproliferative disorders (MPD) form a range of clonal haematological malignant diseases, the main members of which are Polycythaemia Vera (PV), Essential Thrombocythaemia (ET), and Primary Myelofibrosis (PMF). The molecular pathogenesis of these disorders is unknown, but gene JAK2, which encodes a tyrosine kinase was found mutated in MPD ...
Mega Sitorus +2 more
openaire +1 more source
Introduction: Somatic mutation in the exon 14 of Janus Kinase 2 gene is an established diagnostic marker in bcr-abl negative myeloproliferative neoplasms, especially primary idiopathic myelofibrosis (PIMF).
Neha Singh +5 more
doaj +1 more source
Allele burden expansion in <i>JAK2</i> <sup>V617F</sup> and <i>CALR</i>-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment. [PDF]
HemaSphere, Volume 10, Issue 9, September 2026.
Ng ZY +18 more
europepmc +2 more sources
CO‐Rebreathing in Essential Thrombocythemia and Polycythemia Vera. A Revival of an Old Methodology to Improve Diagnosis and Phlebotomy Decisions [PDF]
ABSTRACT The diagnostic landscape for the Philadelphia‐negative myeloproliferative neoplasms (MPNs), particularly in distinguishing Essential Thrombocythemia (ET) from Polycythemia Vera (PV), is compromised. The gold standard for diagnosing PV—measurement of red cell mass (RCM) by radioisotope dilution—has been largely abandoned, leading to widespread ...
Hasselbalch H +10 more
europepmc +2 more sources
OBJECTIVE: Bone marrow fibrosis is the second most common complication causing morbidity and mortality in patients with Philadelphia negative myeloproliferative neoplasms (MPNs).
M. Cem Ar +10 more
doaj +1 more source
The myeloproliferative neoplasms (MPNs) are characterized by an expansion of the neoplastic hematopoietic stem/progenitor cells (HSPC) and an increased risk of cardiovascular complications.
Haotian Zhang +4 more
doaj +1 more source
Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features
Thromboembolic events are the main cause of mortality in BCR-ABL1-negative myeloproliferative neoplasms (MPNs) but their underlying mechanisms are largely unrecognized.
Anna Guadall +15 more
semanticscholar +1 more source
Myeloproliferative neoplasms (MPN) are a group of blood cancers in which the bone marrow (BM) produces an overabundance of erythrocyte, white blood cells, or platelets. Philadelphia chromosome-negative MPN has three subtypes, including polycythemia vera (
Pan-Hong Gou +2 more
semanticscholar +1 more source
The JAK2V617F mutation has been found in most cases of Ph-negative myeloproliferative neoplasms. Recent studies have shown that expression of Jak2V617F in the hematopoietic compartment causes marked expansion of erythroid progenitors and their ...
Hajime Akada +3 more
doaj +1 more source
Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia [PDF]
Classic "BCR-ABL1-negative" MPN is an operational sub-category of MPN that includes polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) harboring JAK2V617F as the most common mutation. JAK2V617F can be detected in about 95 % of patients with PV while remaining 5 % of PV patients carry a somatic mutation of JAK2 exon ...
Munazza, Rashid +5 more
openaire +2 more sources

